Fig. 5.
![Fig. 5. Histopathologic findings in the hindpaw joint of (A) untreated MRL/lpr at 18 weeks of age and (B) MRL/lpr mice treated with CY/2X/Bone/2BMT (56 weeks after the treatment [72 weeks of age]). The joint of the untreated MRL/lpr mouse shows marked lymphoid cell infiltration and pannus formation, whereas the joint of the treated MRL/lpr mouse shows neither lymphoid cell infiltration nor pannus formation.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/91/12/10.1182_blood.v91.12.4616/4/blod412tak05z.jpeg?Expires=1735547843&Signature=xfbyjUsHDiNWGNGeuk-kX41kZd2xL35ILo7Z3ypiOU9pW-BGQSohpfYOH2HIm8PpuVlhlv4-y5kNx1R-QbXeWe5RJXEvQQkD4gpPtUA5Pji0qtL10dfkK2cErJJd2~SQcL7xKEk2Sxfl67URCaGZdQXlKhJTsisGniXB-KN5ECyvNDsQoAytzV8hKmlr5HK4v2m7eht5EvVRao7WDBu~z2qYkwINsY7XIdGCBLWiI8kXV6-0EVne44VlN8V0jMTPjeh6xPNzkxbqKwd1WugGiDsC3TyOk68kF9TfU5g2x2yXrui3m0rusPavKH08FBkLIiLwrq7caWMlh~2GC1~Waw__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Histopathologic findings in the hindpaw joint of (A) untreated MRL/lpr at 18 weeks of age and (B) MRL/lpr mice treated with CY/2X/Bone/2BMT (56 weeks after the treatment [72 weeks of age]). The joint of the untreated MRL/lpr mouse shows marked lymphoid cell infiltration and pannus formation, whereas the joint of the treated MRL/lpr mouse shows neither lymphoid cell infiltration nor pannus formation.
